The Parallax View
Subscribe
Sign in
Home
Archive
About
New
Top
Discussion
$CRTX | Cortexyme
A post-mortem and a look at what’s next
The Parallax View
Mar 8
Share this post
$CRTX | Cortexyme
www.parallax.bio
Copy link
Twitter
Facebook
Email
Cheatsheet: $AUPH | Aurinia
Recapping a year of buyout rumors
The Parallax View
Feb 25
1
Share this post
Cheatsheet: $AUPH | Aurinia
www.parallax.bio
Copy link
Twitter
Facebook
Email
$BNTX | BioNTech: mRNA therapies beyond the COVID-19 vaccine
An exciting approach to auto-immune conditions published in Science shows the broad potential of future mRNA therapies
The Parallax View
Feb 14
2
Share this post
$BNTX | BioNTech: mRNA therapies beyond the COVID-19 vaccine
www.parallax.bio
Copy link
Twitter
Facebook
Email
The State of Biotech Today
Our world in charts
The Parallax View
Feb 9
3
Share this post
The State of Biotech Today
www.parallax.bio
Copy link
Twitter
Facebook
Email
The Biotech Investor's Resources
Use these to help make $XBI a better place
The Parallax View
Jan 18
8
1
Share this post
The Biotech Investor's Resources
www.parallax.bio
Copy link
Twitter
Facebook
Email
Q3 2021 13F Review + Composite Ticker List
The Parallax View
Dec 9, 2021
1
Share this post
Q3 2021 13F Review + Composite Ticker List
www.parallax.bio
Copy link
Twitter
Facebook
Email
$GLUE | Monte Rosa Therapeutics
Drugging the undruggable, not redrugging the druggable
The Parallax View
Oct 13, 2021
4
Share this post
$GLUE | Monte Rosa Therapeutics
www.parallax.bio
Copy link
Twitter
Facebook
Email
$TLIS | Talis, the Dark Horse of Point-of-Care Testing?
COVID-19 Variant & Flu POCT and the New Normal
The Parallax View
Oct 6, 2021
1
Share this post
$TLIS | Talis, the Dark Horse of Point-of-Care Testing?
www.parallax.bio
Copy link
Twitter
Facebook
Email
CD47: Eating Up Cancer and Biobucks
8,500 words on $TRIL $ALXO $IMAB $STTK $OSE $GILD
The Parallax View
Sep 14, 2021
2
Share this post
CD47: Eating Up Cancer and Biobucks
www.parallax.bio
Copy link
Twitter
Facebook
Email
Q2 13F Review
Looking at portfolio changes for RA, Perceptive, Baker, OrbiMed, BVF, EcoR1, Redmile, Opaleye, Ghost Tree
The Parallax View
Aug 20, 2021
3
Share this post
Q2 2021 13F Review
www.parallax.bio
Copy link
Twitter
Facebook
Email
$CCCC | C4 Therapeutics
2,700 words
The Parallax View
Aug 13, 2021
2
Share this post
$CCCC | C4 Therapeutics
www.parallax.bio
Copy link
Twitter
Facebook
Email
Exclusive: $NRIX | Nurix Therapeutics
1,500 words
The Parallax View
Aug 11, 2021
1
Share this post
Exclusive: $NRIX | Nurix Therapeutics
www.parallax.bio
Copy link
Twitter
Facebook
Email
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts